In addition, these Regulatory T cells regulate other injury healing cells to the site, flooding the injury with beneficial ...

The new study gathered general practitioners’ (GPs) views on providing contraceptive care during the ‘6-week check’ – a routine medical review of mother and baby 6-8 weeks after birth. Conducted by ...

Of the 24.3% of the cohort diagnosed with silicosis, 6.6% had very high levels of anti-nuclear antibodies. Importantly the researchers also found associations between autoantibodies and age, smoking, ...

The Australian Evidence-based Guideline for unexplained infertility advances our understanding of infertility prognosis and treatment and has new evidence-based recommendations so that women and their ...

mRNA Core is a collaborative initiative to advance the next generation of mRNA. Based at MIPS and currently funded by an MRFF mRNA Clinical Trials Enabling Grant and NCRIS, the facility is one of the ...

Join a forward-thinking academic community and make your mark in solving global economic, environmental, and social challenges. Our Integrated PhD program is highly competitive and meeting our ...

In a discovery that challenges our understanding of Earth’s ancient history, researchers have found evidence suggesting that Earth may have had a ring system, which formed around 466 million years ago ...

This option offers the opportunity to work with leading business law scholars on projects that make a genuine and substantive impact on global economic, environmental, and social challenges. Our ...

The Integrated PhD program offers an exceptional opportunity to make a significant impact and fast-track your career. Network with like-minded peers and world-leading academics as you become a part of ...

The Monash Centre for Advanced mRNA Medicines Manufacturing and Workforce Training is Australia’s first dedicated mRNA workforce training centre, established as an initiative by mRNA Victoria and with ...

Building on years of expertise in nucleic acid delivery and nanomedicine design, the COVID-19 pandemic accelerated MIPS scientists' development of mRNA therapeutics using lipid-nanoparticle-based ...